Distinct expression and regulation of the glutamate transporter isoforms GLT-1a and GLT-1b in cultured astrocytes from a rat model of amyotrophic lateral sclerosis (hSOD1G93A)

Neurochemistry International

Volumn 55, Issue 1-3, 2009, Pages 28-34

  Goursaud, Stéphanie ^a   Maloteaux, Jean Marie ^a   Hermans, Emmanuel ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Amyotrophic lateral sclerosis; Cortical astrocytes; GLT 1a and GL 1b; hSOD1G93A rats; Peptide Histidine Isoleucine

Indexed keywords

ASPARTIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; DEXTRO ASPARTIC ACID; MESSENGER RNA; PEPTIDE HISTIDINE ISOLEUCINE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 1 A; VESICULAR GLUTAMATE TRANSPORTER 1 B;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ASPARTIC ACID; ASTROCYTES; CELLS, CULTURED; EXCITATORY AMINO ACID TRANSPORTER 2; HUMANS; KINETICS; PEPTIDE PHI; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SUPEROXIDE DISMUTASE;

ANIMALIA; RATTUS;

EID: 64949105785     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.02.003     Document Type: Article

References (44)

1. Aoki M., Lin C.L., Rothstein J.D., Geller B.A., Hosler B.A., Munsat T.L., Horvitz H.R., and Brown Jr. R.H. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann. Neurol. 43 (1998) 645-653
2. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., and Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14 (1994) 5559-5569
3. Bassan M., Liu H., Madsen K.L., Armsen W., Zhou J., DeSilva T., Chen W., Paradise A., Brasch M.A., Staudinger J., Gether U., Irwin N., and Rosenberg P.A. Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1. Eur. J. Neurosci. 27 (2008) 66-82
4. Berger U.V., DeSilva T.M., Chen W., and Rosenberg P.A. Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization. J. Comp. Neurol. 492 (2005) 78-89
5. Bristol L.A., and Rothstein J.D. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann. Neurol. 39 (1996) 676-679
6. Brown D.R. Neuronal release of vasoactive intestinal peptide is important to astrocytic protection of neurons from glutamate toxicity. Mol. Cell Neurosci. 15 (2000) 465-475
7. Chen W., Aoki C., Mahadomrongkul V., Gruber C.E., Wang G.J., Blitzblau R., Irwin N., and Rosenberg P.A. Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain. J. Neurosci. 22 (2002) 2142-2152
8. Chen W., Mahadomrongkul V., Berger U.V., Bassan M., DeSilva T., Tanaka K., Irwin N., Aoki C., and Rosenberg P.A. The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. J. Neurosci. 24 (2004) 1136-1148
9. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
10. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol. Ther. 81 (1999) 163-221
11. Flowers J.M., Powell J.F., Leigh P.N., Andersen P., and Shaw C.E. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis. Ann. Neurol. 49 (2001) 643-649
12. Fray A.E., Ince P.G., Banner S.J., Milton I.D., Usher P.A., Cookson M.R., and Shaw P.J. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study. Eur. J. Neurosci. 10 (1998) 2481-2489
13. Fumagalli E., Funicello M., Rauen T., Gobbi M., and Mennini T. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur. J. Pharmacol. 578 (2008) 171-176
14. Goursaud S., Maloteaux J.M., and Hermans E. Activation of VIP/PACAP type 2 receptor by the peptide histidine isoleucine in astrocytes influences GLAST-mediated glutamate uptake. J. Neurochem. 105 (2008) 1165-1175
15. Goursaud S., Kozlova E.N., Maloteaux J.M., and Hermans E. Cultured astrocytes derived from corpus callosum or cortical grey matter show distinct glutamate handling properties. J. Neurochem. 108 (2009) 1442-1452
16. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., and Deng H.X. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
17. Honig L.S., Chambliss D.D., Bigio E.H., Carroll S.L., and Elliott J.L. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology 55 (2000) 1082-1088
18. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., and Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 1604-1609
19. +-coupled glutamate/aspartate transport by a rat brain astrocyte line expressing GLAST and EAAC1. J. Membr. Biol. 182 (2001) 17-30
20. Kosugi T., and Kawahara K. Reversed actrocytic GLT-1 during ischemia is crucial to excitotoxic death of neurons, but contributes to the survival of astrocytes themselves. Neurochem. Res. 31 (2006) 933-943
21. Kozlova E.N., and Takenaga K. A procedure for culturing astrocytes from white matter and the application of the siRNA technique for silencing the expression of their specific marker, S100A4. Brain Res. Brain Res. Protoc. 15 (2005) 59-65
22. Li L.B., Toan S.V., Zelenaia O., Watson D.J., Wolfe J.H., Rothstein J.D., and Robinson M.B. Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J. Neurochem. 97 (2006) 759-771
23. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., and Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20 (1998) 589-602
24. Maragakis N.J., Dykes-Hoberg M., and Rothstein J.D. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann. Neurol. 55 (2004) 469-477
25. Maragakis N.J., and Rothstein J.D. Glutamate transporters: animal models to neurologic disease. Neurobiol. Dis. 15 (2004) 461-473
26. Meyer T., Fromm A., Munch C., Schwalenstocker B., Fray A.E., Ince P.G., Stamm S., Gron G., Ludolph A.C., and Shaw P.J. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J. Neurol. Sci. 170 (1999) 45-50
27. Nagai M., Abe K., Okamoto K., and Itoyama Y. Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci. Lett. 244 (1998) 165-168
28. Nagai M., Aoki M., Miyoshi I., Kato M., Pasinelli P., Kasai N., Brown Jr. R.H., and Itoyama Y. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J. Neurosci. 21 (2001) 9246-9254
29. Pow D.V., Naidoo T., Lingwood B.E., Healy G.N., Williams S.M., Sullivan R.K., O'Driscoll S., and Colditz P.B. Loss of glial glutamate transporters and induction of neuronal expression of GLT-1B in the hypoxic neonatal pig brain. Brain Res. Dev. Brain Res. 153 (2004) 1-11
30. Rangon C.M., Goursaud S., Medja F., Lelievre V., Mounien L., Husson I., Brabet P., Jegou S., Janet T., and Gressens P. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice. J. Pharmacol. Exp. Ther. 314 (2005) 745-752
31. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., and Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16 (1996) 675-686
32. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes H.M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., and Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433 (2005) 73-77
33. Sasaki S., Komori T., and Iwata M. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis. Acta Neuropathol. 100 (2000) 138-144
34. Schmitt A., Asan E., Lesch K.P., and Kugler P. A splice variant of glutamate transporter GLT1/EAAT2 expressed in neurons: cloning and localization in rat nervous system. Neuroscience 109 (2002) 45-61
35. Shobha K., Vijayalakshmi K., Alladi P.A., Nalini A., Sathyaprabha T.N., and Raju T.R. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. J. Neurol. Sci. 254 (2007) 9-16
36. Siddique, T., Deng, H.X., 1996. Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet., 1465-1470 (5 Spec No.).
37. Tilleux S., and Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J. Neurosci. Res. 85 (2007) 2059-2070
38. Tortarolo M., Crossthwaite A.J., Conforti L., Spencer J.P., Williams R.J., Bendotti C., and Rattray M. Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress. J. Neurochem. 88 (2004) 481-493
39. Trotti D., Aoki M., Pasinelli P., Berger U.V., Danbolt N.C., Brown Jr. R.H., and Hediger M.A. Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity. J. Biol. Chem. 276 (2001) 576-582
40. Van den Bosch L., Van Damme P., Bogaert E., and Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762 (2006) 1068-1082
41. Vermeiren C., de Hemptinne I., Vanhoutte N., Tilleux S., Maloteaux J.M., and Hermans E. Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis. J. Neurochem. 96 (2006) 719-731
42. Vermeiren C., Najimi M., Maloteaux J.M., and Hermans E. Molecular and functional characterisation of glutamate transporters in rat cortical astrocytes exposed to a defined combination of growth factors during in vitro differentiation. Neurochem. Int. 46 (2005) 137-147
43. Yi J.H., Pow D.V., and Hazell A.S. Early loss of the glutamate transporter splice-variant GLT-1v in rat cerebral cortex following lateral fluid-percussion injury. Glia 49 (2005) 121-133
44. Zschocke J., Bayatti N., Clement A.M., Witan H., Figiel M., Engele J., and Behl C. Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions. J. Biol. Chem. 280 (2005) 34924-34932